Stock listing
Cytomx Therapeutics, Inc.
Selected listing: 6C1 · GETTEX · EUR · DE
Cytomx Therapeutics, Inc. (gettex:6C1), Health Technology. Latest release Aug 27, 2026: CytomX Therapeutics Announces FDA Fast Track Designation…
- Ticker
- gettex:6C1
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- gettex
- Currency
- EUR
Latest news from Cytomx Therapeutics, Inc.
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
August 27, 2026
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
August 6, 2026
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
August 3, 2026
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
July 27, 2026
Events
Research Cytomx Therapeutics, Inc.
Cytomx Therapeutics, Inc. company profile
View the public company page for Cytomx Therapeutics, Inc. on 6ix.
Cytomx Therapeutics, Inc. news
Read company news and market updates connected to Cytomx Therapeutics, Inc..
Cytomx Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Cytomx Therapeutics, Inc..
Alternate listings
CTMX:NASDAQ
US · USD
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
A14158:LSX
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
A14158:LS
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
6C1:TRADEGATE
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
6C1:FWB
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
CTMX:BOATS
US · USD
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
6C1:BX
CH · CHF
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
6C1:DUS
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.
6C1:SWB
DE · EUR
Alternate listing for Cytomx Therapeutics, Inc.; the primary context on this page is 6C1:GETTEX.